Immediate protamine administration and sheath removal following percutaneous coronary intervention: A prospective study of 429 patients

Catheterization and Cardiovascular Interventions

Volumn 56, Issue 2, 2002, Pages 196-199

  Ducas, John ^a   Chan, Michael C Y ^a   Miller, Anthony ^a   Kashour, Tarek ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Angioplasty; Anticoagulants; Protamines; Stents

Indexed keywords

CREATINE KINASE; FIBRINOGEN RECEPTOR ANTAGONIST; PROTAMINE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEMOSTASIS, SURGICAL; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTAMINES; PUNCTURES; STENTS; TICLOPIDINE;

EID: 0036263921     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10195     Document Type: Article

References (18)

1. Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge
2. Vasoseal hemostasis following coronary interventions with abciximab
3. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The ACCESS study
4. Low-dose heparin for routine coronary angioplasty and stenting
5. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
6. Early ambulation after coronary angioplasty and stenting with six French guiding catheters and low-dose heparin
7. Safety of low dose heparin in elective coronary angioplasty
8. Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparin
9. Immediate femoral sheath removal after 6 French routine coronary angioplasty with a weight-adjusted low-dose heparin: Results of a prospective registry
10. Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention
11. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation
12. Administration of protamine after coronary stent deployment
13. Evaluation of platelet IIb/IIIa inhibitor for stenting: Randomised placebo-controlled and balloonangioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
14. Peripheral vascular complications following coronary interventional procedures
15. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty
16. Prolonged heparin after uncomplicated coronary interventions: A prospective, randomized trial
17. Heparin after percutaneous intervention (HAPI): A prospective multicenter randomized trial of three heparin regimens after successful coronary intervention
18. Minimal heparinization in coronary angioplasty: How much heparin is really warranted?